Computational pathology: A path ahead

Archives of Pathology and Laboratory Medicine

Volumn 140, Issue 1, 2016, Pages 41-50

  Louis, David N ^a   Feldman, Michael ^b   Carter, Alexis B ^c   Dighe, Anand S ^a   Pfeifer, John D ^d   Bry, Lynn ^e   Almeida, Jonas S ^f   Saltz, Joel ^f   Braun, Jonathan ^g   Tomaszewski, John E ^h   Gilbertson, John R ^a   Sinard, John H ⁱ   Gerber, Georg K ^e   Galli, Stephen J ^j   Golden, Jeffrey A ^e   Becich, Michael J ^k  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f Stony Brook University   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY AT BUFFALO   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j STANFORD UNIVERSITY   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; DOCTOR PATIENT RELATION; HEALTH CARE SYSTEM; HUMAN; MEDICAL PRACTICE; PATHOLOGIST; PATHOLOGY; PIPELINE; UNITED STATES; BIOLOGY; PROCEDURES; TRENDS;

COMPUTATIONAL BIOLOGY; HUMANS; PATHOLOGY, CLINICAL;

EID: 84954290310     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2015-0093-SA     Document Type: Article

References (51)

1. Kulikowski CA, Shortliffe EH, Currie LM, et al. AMIA Board white paper: definition of biomedical informatics and specification of core competencies for graduate education in the discipline. J Am Med Inform Assoc. 2012;19(6):931-938.
2. Louis DN, Gerber GK, Baron JM, et al. Computational pathology: an emerging definition. Arch Pathol Lab Med. 2014;138(9):1133-1138.
3. Higgins JM, Mahadevan L. Physiological and pathological population dynamics of circulating human red blood cells. Proc Natl Acad Sci U S A. 2010; 107(47):20587-20592.
4. Lara J, Lopez-Labrador F, Gonzalez-Candelas F, Berenguer M, Khudyakov YE. Computational models of liver fibrosis progression for hepatitis C virus chronic infection. BMC Bioinformatics. 2014;15(suppl 8):S5.
5. Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;Chapter 7: Unit7.20.
6. Flanagan SE, Patch AM, Ellard S. Using SIFT and PolyPhen to predict lossof-function and gain-of-function mutations. Genet Test Mol Biomarkers. 2010; 14(4):533-537.
7. Hu J, Ng PC. SIFT Indel: predictions for the functional effects of amino acid insertions/deletions in proteins. PLoS One. 2013;8(10):e77940.
8. Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40(Web Server issue):W452-W457.
9. Zou M, Baitei EY, Alzahrani AS, et al. Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutations. Endocrine. 2011;40(1):14-20.
10. dbSNP: Short Genetic Variations [database online]. Bethesda, MD: National Center for Biotechnology Information. http://www.ncbi.nlm.nih.gov/ projects/SNP/snp-tableList.cgi. Accessed September 10, 2014.
11. NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2014;42(Database issue):D7-D17.
12. Catalogue of Somatic Mutations in Cancer (COSMIC) [database online]. Cambridge, UK: Wellcome Trust Sanger Institute; 2014. http://cancer.sanger.ac. uk/cancergenome/projects/cosmic/. Accessed August 5, 2014.
13. Bamford S, Dawson E, Forbes S, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer. 2004;91(2):355-358.
14. Landrum MJ, Lee JM, Riley GR, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(Database issue):D980-D985.
15. Riggs ER, Wain KE, Riethmaier D, et al. Towards a universal clinical genomics database: the 2012 International Standards for Cytogenomic Arrays Consortium Meeting. Hum Mutat. 2013;34(6):915-919.
16. The ClinGen Resource [database online]. Bethesda, MD: National Institutes of Health. http://clinicalgenome.org/. Accessed April 1, 2015.
17. Raess PW, van de Geijn GJ, Njo TL, et al. Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters. Am J Hematol. 2014;89(4):369-374.
18. Aronson SJ, Clark EH, Babb LJ, et al. The GeneInsight Suite: a platform to support laboratory and provider use of DNA-based genetic testing. Hum Mutat. 2011;32:532-536.
19. Wilcox AR, Neri PM, Volk LA, et al. A novel clinician interface to improve clinician access to up-to-date genetic results. J Am Med Inform Assoc. 2013;21: e117-e121.
20. Desmond-Hellman S, Sawyers CL, Cox DR, et al. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. 1st ed. Washington, DC: The National Academies Press; 2015.
21. National Institutes of Health. Precision Medicine Initiative Web site. http:// www.nih.gov/precisionmedicine/. Accessed February 23, 2015.
22. Colen R, Foster I, Gatenby R, et al. NCI Workshop Report: clinical and computational requirements for correlating imaging phenotypes with genomics signatures. Transl Oncol. 2014;7(5):556-569.
23. Cooper LA, Kong J, Gutman DA, et al. Integrated morphologic analysis for the identification and characterization of disease subtypes. J Am Med Inform Assoc. 2012;19(2):317-323.
24. Boca SM, Bravo HC, Caffo B, Leek JT, Parmigiani G. A decision-theory approach to interpretable set analysis for high-dimensional data. Biometrics. 2013;69(3):614-623.
25. Leiserson MD, Vandin F, Wu HT, et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet. 2015;47(2):106-114.
26. Madabhushi A, Doyle S, Lee G, et al. Integrated diagnostics: a conceptual framework with examples. Clin Chem Lab Med. 2010;48(7):989-998.
27. Gerber GK. The dynamic microbiome. FEBS Lett. 2014;588(22):4131-4139.
28. Gerber GK, Onderdonk AB, Bry L. Inferring dynamic signatures of microbes in complex host ecosystems. PLoS Comput Biol. 2012;8(8):e1002624.
29. Murphy S, Churchill S, Bry L, et al. Instrumenting the health care enterprise for discovery research in the genomic era. Genome Res. 2009;19(9):1675-1681.
30. National Cancer Institute. caLIMS v2 Software [wiki]. https://wiki.nci.nih. gov/display/caLIMS2/caLIMS+v2+Software. Accessed May 25, 2015.
31. National Center for Biomedical Computing. i2b2: Informatics for Integrating Biology & the Bedside Web site. https://www.i2b2.org/. Accessed December 14, 2014.
32. National Cancer Institute. caBIG Web site. http://cabig.cancer.gov/. Accessed December 14, 2014.
33. Garcia CA, Baron JM, Beckwith BA, et al. Environmental components and methods for engaging pathology residents in informatics training. J Pathol Inform. 2015;6:42.
34. Levy BP, McClintock DS, Lee RE, et al. Different tracks for pathology informatics fellowship training: experiences of and input from trainees in a large multisite fellowship program. J Pathol Inform. 2012;3:30.
35. Mandl KD, Kohane IS. Escaping the EHR trap - the future of health IT. N Engl J Med. 2012;366(24):2240-2242.
36. Park S, Parwani AV, Aller R, et al. The history of pathology informatics: a global perspective. J Pathol Inform. 2013;4(1):7-42.
37. Wilkinson SR, Almeida JS. QMachine: commodity supercomputing in web browsers. BMC Bioinformatics. 2014;15:176.
38. Cain MD, Siebert JR, Iriabho E, Gruneberg A, Almeida JS, Faye-Petersen OM. Development of novel software to generate anthropometric norms at perinatal autopsy. Pediatr Dev Pathol. 2015;18(3):203-209.
39. Roth KA, Almeida JS. Coming into focus: computational pathology as the new big data microscope. Am J Pathol. 2015;185(3):600-601.
40. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9): 5116-5121.
41. Li J, Witten DM, Johnstone IM, Tibshirani R. Normalization, testing, and false discovery rate estimation for RNA-sequencing data. Biostatistics. 2012; 13(3):523-538.
42. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large Bcell lymphoma identified by gene expression profiling. Nature. 2000;403(6769): 503-511.
43. Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A. 2002;99(20):12963-12968.
44. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869-10874.
45. Beck AH, Sangoi AR, Leung S, et al. Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci Transl Med. 2011;3(108):108ra113.
46. Dutta-Moscato J, Gopalakrishnan V, Lotze MT, Becich MJ. Creating a pipeline of talent for informatics: STEM initiative for high school students in computer science, biology, and biomedical informatics. J Pathol Inform. 2014;5: 12.
47. US Food and Drug Administration. Draft guidance for industry, Food and Drug Administration staff, and clinical laboratories: framework for regulatory oversight of laboratory developed tests (LDTs). 2015. http://www.fda.gov/ downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ ucm416685.pdf. Accessed May 25, 2015.
48. US Food and Drug Administration. Draft guidance for industry, Food and Drug Administration staff, and clinical laboratories: FDA notification and medical device reporting for laboratory developed tests (LDTs). October 3, 2014. http:// www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/UCM416684.pdf. Accessed February 23, 2015.
49. Clinical Laboratory Improvement Amendments of 1988. Laboratory Requirements, 42 CFR §493. http://www.gpo.gov/fdsys/pkg/CFR-2012-title42-vol5/pdf/CFR-2012-title42-vol5-part493.pdf. Accessed February 23, 2015.
50. US Food and Drug Administration. Public Workshop-Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs), January 8-9, 2015. http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ ucm423537.htm. Accessed February 23, 2015.
51. US Food and Drug Administration. Warning letters: FDA inspections, compliance, enforcement, and criminal investigations. http://www.fda.gov/ICECI/ EnforcementActions/WarningLetters/default.htm. Accessed February 23, 2015.